HEPION PHARMACEUTICALS, INC. Accrued Liabilities, Current
HEPION PHARMACEUTICALS, INC. (HEPA) had Accrued Liabilities, Current of $322.88 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $322.88K.
- 2026-03-31: Accrued Liabilities, Current $347.13K.
- 2025-12-31: Accrued Liabilities, Current $77.51K.
- 2025-09-30: Accrued Liabilities, Current $55.86K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $322.88K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $347.13K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $77.51K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $55.86K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $48.49K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $166.49K 10-Q · filed 2025-05-19 | |
| 2024-12-31 | $23.68K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $306.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $375.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $793.75K 10-Q · filed 2024-05-21 | |
| 2023-12-31 | $2.44M 10-K · filed 2025-04-08 | |
| 2023-09-30 | $2.91M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $3.11M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.26M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $4.80M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $4.76M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.29M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.63M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.51M 10-K · filed 2023-04-10 | |
| 2021-09-30 | $2.21M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.67M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $817.28K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $659.57K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $2.38M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.36M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $412.84K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $851.20K 10-K · filed 2021-03-31 | $493.64K 10-K · filed 2020-05-14 |
| 2019-09-30 | $308.39K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $535.15K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $657.07K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $661.42K 10-K · filed 2020-05-14 | |
| 2018-09-30 | $421.38K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $920.32K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $831.34K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.05M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.33M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.32M 10-KT · filed 2018-03-26 | |
| 2017-03-31 | $910.83K 10-Q · filed 2017-04-12 | |
| 2016-12-31 | $921.19K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $765.05K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $820.89K 10-KT · filed 2018-03-26 | |
| 2016-03-31 | $847.43K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $598.88K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $1.02M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $456.72K 10-K · filed 2016-09-28 | |
| 2015-03-31 | $302.71K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $246.54K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $244.44K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $207.91K 10-K · filed 2015-09-25 | |
| 2014-03-31 | $66.67K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $33.56K 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $36.00K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $40.00K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |